Health implications of high-fructose intake and current research

Advances in Nutrition

Volumn 6, Issue 6, 2015, Pages 729-737

  Dornas, Waleska C ^a   de Lima, Wanderson G ^a   Pedrosa, Maria L ^a   Silva, Marcelo E ^b  

^a Institute of Exact and Biological Sciences   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Antioxidants; Fructose; Hypertension; Oxidative stress; Sugar sweetened beverages

Indexed keywords

FRUCTOSE; INSULIN; SUGAR INTAKE; URIC ACID;

ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; DIET; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC DISEASES; METABOLISM; MOUSE; OBESITY; RAT; RISK FACTOR; SUGAR INTAKE; WEIGHT GAIN;

ANIMALS; DIET; DIETARY SUCROSE; FRUCTOSE; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC DISEASES; MICE; OBESITY; RATS; RISK FACTORS; URIC ACID; WEIGHT GAIN;

EID: 84953335667     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.114.008144     Document Type: Review

References (103)

1. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose cornsyrup in beverages may play a role in the epidemic of obesity. Am JClin Nutr 2004;79:537-43.
2. Park YK, Yetley EA. Intakes of food sources of fructose in the UnitedStates. Am J Clin Nutr 1993;58:737S-47S.
3. Hanover LM, White JS. Manufacturing, composition, and applicationsof fructose. Am J Clin Nutr 1993;58:724S-32S.
4. Mayes PA. Intermediary metabolism of fructose. Am J Clin Nutr 1993;58: Suppl:754S-65S.
5. Van Schaftingen E. The discovery and role of fructose-2,6-bisphosphatate.Acta Gastroenterol Belg 1988;51:141-6.
6. Tornheim K, Lowenstein JM. Control of phosphofructokinase fromrat skeletal muscle: effects of fructose diphosphate, AMP, ATP, and citrate.J Biol Chem 1976;251:7322-8.
7. Uusitupa MIJ. Fructose in the diabetic diet. Am J Clin Nutr 1994;59:753S-7S.
8. Bar-On H, Stein Y. Effect of glucose and fructose administration onlipid metabolism in the rat. J Nutr 1968;94:95-105.
9. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM,Johnson RJ, Abdelmalek MF. Fructose consumption as a risk factorfor nonalcoholic fatty liver disease. J Hepatol 2008;48:993-9.
10. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest2000;106:171-6.
11. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetesmellitus. Trends Endocrinol Metab 2000;11:351-6.
12. Lê KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, TappyL. Fructose overconsumption causes dyslipidemia and ectopic lipiddeposition in healthy subjects with and without a family history oftype 2 diabetes. Am J Clin Nutr 2009;89:1760-5.
13. Jeppesen J, Chen YI, Zhou MY, Schaaf P, Coulston A, Reaven GM.Postprandial triglyceride and retinyl ester responses to oral fat: effectsof fructose. Am J Clin Nutr 1995;61:787-91.
14. Abraha A, Humphreys SM, Clark ML, Matthews DR, Frayn KN. Acuteeffect of fructose on postprandial lipaemia in diabetic and nondiabeticsubjects. Br J Nutr 1998;80:169-75.
15. Teff KL, Elliott SS, Tschöp M, Kieffer TJ, Rader D, Heiman M, TownsendRR, Keim NL, D'Alessio D, Havel PJ. Dietary fructose reduces circulatinginsulin and leptin, attenuates postprandial suppression of ghrelin, andincreases triglycerides in women. J Clin Endocrinol Metab 2004;89:2963-72.
16. Lê KA, Faeh D, Stettler R, Ith M, Kreis R, Vermathen P, Boesch C,Ravussin E, Tappy L. A 4-wk high-fructose diet alters lipid metabolismwithout affecting insulin sensitivity or ectopic lipids in healthy humans.Am J Clin Nutr 2006;84:1374-9.
17. Assy N, Nasser G, Kamayse I, NseirW, Beniashvili Z, Djibre A, GrosovskiM. Soft drink consumption linked with fatty liver in the absence of traditionalrisk factors. Can J Gastroenterol 2008;22:811-6.
18. Rizkalla SW, Lebouc Y, Serog P, Apfelbaum M. Carbohydrate intake affectsinsulin binding to human erythrocytes in normal weight subjectsbut not in subjects with family obesity. Metabolism 1981;30:900-7.
19. Crapo PA, Kolterman OG. The metabolic effects of 2-week fructosefeeding in normal subjects. Am J Clin Nutr 1984;39:525-34.
20. Lê KA, Faeh D, Stettler R, Debard C, Loizon E, Vidal H, Boesch C, RavussinE, Tappy L. Effects of four-week high-fructose diet on gene expression inskeletal muscle of healthy men. Diabetes Metab 2008;34:82-5.
21. Pagliassotti MJ, Prach PA, Koppenhafer TA, Pan DA. Changes in insulinaction, triglycerides, and lipid composition during sucrose feedingin rats. Am J Physiol 1996;271:R1319-26.
22. Catena C, Cavarape A, Novello M, Giacchetti G, Sechi LA. Insulin receptorsand renal sodium handling in hypertensive fructose-fed rats.Kidney Int 2003;64:2163-71.
23. Ueno M, Bezerra RM, Silva MS, Tavares DQ, Carvalho CR, Saad MJ.A high-fructose diet induces changes in pp185 phosphorylation inmuscle and liver of rats. Braz J Med Biol Res 2000;33:1421-7.
24. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. Fructoseinducedin vivo insulin resistance and elevated plasma triglyceride levelsin rats. Am J Clin Nutr 1989;49:1155-63.
25. Liu IM, Tzeng TF, Liou SS. A Chinese herbal decoction, Dang Gui BuXue Tang, prepared from Radix astragali and Radix angelicae sinensis,ameliorates insulin resistance induced by a high-fructose diet in rats.Evid Based Complement Alternat Med 2011;248231:1-11.
26. Roglans N, Vila L, Farre M, Alegret M, Sanchez RM, Vazquez-CarreraM, Laguna JC. Impairment of hepatic Stat-3 activation and reductionof PPARalpha activity in fructose-fed rats. Hepatology 2007;45:778-88.
27. Shimomura I, Bashmakov Y, Horton JD. Increased levels of nuclearSREBP-1c associated with fatty livers in two mouse models of diabetesmellitus. J Biol Chem 1999;274:30028-32.
28. Stanhope KL, Griffen SC, Bair BR, Swarbrick MM, Keim NL, Havel PJ.Twenty-four-hour endocrine and metabolic profiles following consumptionof high-fructose corn syrup-, sucrose-, fructose-, and glucosesweetenedbeverages with meals. Am J Clin Nutr 2008;87:1194-203.
29. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, GrahamJL, Hatcher B, Cox CL, Dyachenko A, Zhang W, et al. Consumingfructose sweetened, not glucose-sweetened, beverages increases visceraladiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322-34.
30. DiMeglio DP, Mattes RD. Liquid versus solid carbohydrate: effects onfood intake and body weight. Int J Obes Relat Metab Disord 2000;24:794-800.
31. Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumptionof sugar-sweetened drinks and childhood obesity: a prospective,observational analysis. Lancet 2001;357:505-8.
32. Raben A, Vasilaras TH, Moller AC, Astrup A. Sucrose compared withartificial sweeteners: different effects on ad libitum food intake andbody weight after 10 wk of supplementation in overweight subjects.Am J Clin Nutr 2002;76:721-9.
33. Kurtz TW, Kabra PM, Booth BE, Al-Bander HA, Portale AA, SerenaBG, Tsai HC, Morris RC, Jr. Liquid-chromatographic measurementsof inosine, hypoxanthine, and xanthine in studies of fructose-induceddegradation of adenine nucleotides in humans and rats. Clin Chem1986;32:782-6.
34. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides anantioxidant defense in humans against oxidant- and radical-caused agingand cancer: a hypothesis. Proc Natl Acad Sci USA 1981;78:6858-62.
35. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acidand serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis2000;148:131-9.
36. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of theclassic antioxidant uric acid in adipocytes: NADPH oxidase-mediatedoxidative/nitrosative stress. Am J Physiol Cell Physiol 2007;293:C584-96.
37. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smoothmuscle cell proliferation by increasing platelet-derived growth factorA-chain expression. J Biol Chem 1991;266:8604-8.
38. Zare F, Magnusson M, Bergström T, Brisslert M, Josefsson E, KarlssonA, Tarkowski A. Uric acid, a nucleic acid degradation product, downregulatesdsRNA-triggered arthritis. J Leukoc Biol 2006;79:482-8.
39. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactiveprotein expression: implication on cell proliferation and nitric oxideproduction of human vascular cells. J Am Soc Nephrol 2005;16:3553-62.
40. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K.Serum uric acid and risk for development of hypertension and impairedfasting glucose or type II diabetes in Japanese male officeworkers. Eur J Epidemiol 2003;18:523-30.
41. Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, WagenknechtLE, Wofford MR, Herrington DM. Serum uric acid predicts incidenthypertension in a biethnic cohort: the atherosclerosis risk in communitiesstudy. Hypertension 2006;48:1037-42.
42. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individualswith hyperuricemia. Am J Med 2007;120:442-7.
43. Fox IH, Kelley WN. Studies on the mechanism of fructose-inducedhyperuricemia in man. Metabolism 1972;21:713-21.
44. Emmerson BT. Effect of oral fructose on urate production. AnnRheum Dis 1974;33:276-80.
45. Macdonald I, Keyser A, Pacy D. Some effects, in man, of varying theload of glucose, sucrose, fructose, or sorbitol on various metabolites inblood. Am J Clin Nutr 1978;31:1305-11.
46. Turner JL, Bierman EL, Brunzell JD, Chait A. Effect of dietary fructoseon triglyceride transport and glucoregulatory hormones in hypertriglyceridemicmen. Am J Clin Nutr 1979;32:1043-50.
47. Choi JW, Ford ES, Gao X, Choi HK. Sugar sweetened soft drinks, dietsoft drinks, and serum uric acid level: the Third National Health andNutrition Examination Survey. Arthritis Rheum 2008;59:109-16.
48. Sun SZ, Flickinger BD, Williamson-Hughes PS, Empie MW. Lack ofassociation between dietary fructose and hyperuricemia risk in adults.Nutr Metab (Lond) 2010;7:16.
49. Wang DD, Sievenpiper JL, de Souza RJ, Chiavaroli L, Ha V, Cozma AI,Mirrahimi A, Yu ME, Carleton AJ, Di Buono M, et al. The effects offructose intake on serum uric acid vary among controlled dietarytrials. J Nutr 2012;142:916-23.
50. Baron AD, Steinberg HO, Chaker H, Leaming R, Johnson A, BrechtelG. Insulin-mediated skeletal muscle vasodilation contributes to bothinsulin sensitivity and responsiveness in lean humans. J Clin Invest1995;96:786-92.
51. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulinmediatedskeletal muscle vasodilation is nitric oxide dependent: anovel action of insulin to increase nitric oxide release. J Clin Invest1994;94:1172-9.
52. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, BaronAD. Obesity/insulin resistance is associated with endothelial dysfunction:implications for the syndrome of insulin resistance. J Clin Invest1996;97:2601-10.
53. Choi YJ, Yoon Y, Lee KY, Hien TT, Kang KW, Kim KC, Lee J, Lee MY,Lee SM, Kang DH, et al. Uric acid induces endothelial dysfunction byvascular insulin resistance associated with the impairment of nitricoxide synthesis. FASEB J 2014;28:3197-204.
54. Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, Tiribelli C,Bedogni G. Predictors of nonalcoholic fatty liver disease in obese children.Eur J Clin Nutr 2007;61:877-83.
55. Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid levelwith non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol2009;50:1029-34.
56. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension.Hypertension 2003;42:247-52.
57. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowingthe progression of renal disease through its ability to lower serum uricacid level. Am J Kidney Dis 2006;47:51-9.
58. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH,Gersch MS, Benner S, Sánchez-Lozada LG. Potential role of sugar(fructose) in the epidemic of hypertension, obesity and the metabolicsyndrome, diabetes, kidney disease, and cardiovascular disease. Am JClin Nutr 2007;86:899-906.
59. Dornas WC, de Lima WG, dos Santos RC, Guerra JF, de Souza MO,Silva M, Souza e Silva L, Diniz MF, Silva ME. High dietary salt decreasesantioxidant defenses in the liver of fructose-fed insulin-resistantrats. J Nutr Biochem 2013;24:2016-22.
60. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O,Ouyang X, Feig DI, Block ER, Herrera-Acosta J, et al. A causal role foruric acid in fructose-induced metabolic syndrome. Am J Physiol RenalPhysiol 2006;290:F625-31.
61. Sánchez-Lozada LG, Tapia E, Bautista-García P, Soto V, Avila-CasadoC, Vega-Campos IP, Nakagawa T, Zhao L, Franco M, Johnson RJ. Effectsof febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2008;294:F710-8.
62. Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M,Roncal-Jimenez CA, Ishimoto T, Li N, Marek G, Duranay M, et al.Uric acid induces hepatic steatosis by generation of mitochondrial oxidativestress: potential role in fructose-dependent and -independentfatty liver. J Biol Chem 2012;287:40732-44.
63. Wexler BC. Allantoxan amide-induced myocardial necrosis inSprague-Dawley vs spontaneously hypertensive rats. Proc Soc ExpBiol Med 1982;170:476-85.
64. Wexler BC, Greenberg BP. Effect of increased serum urate levels onvirgin rats with no arteriosclerosis versus breeder rats with preexistentarteriosclerosis. Metabolism 1977;26:1309-20.
65. Sánchez-Lozada LG, Tapia E, Jiménez A, Bautista P, Cristóbal M,Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ,et al. Fructose-induced metabolic syndrome is associated with glomerularhypertension and renal microvascular damage in rats. Am J PhysiolRenal Physiol 2007;292:F423-9.
66. Gersch MS, Mu W, Cirillo P, Reungjui S, Zhang L, Roncal C, SautinYY, Johnson RJ, Nakagawa T. Fructose but not dextrose acceleratesthe progression of chronic kidney disease. Am J Physiol Renal Physiol2007;293:F1256-61.
67. De Angelis K, Senador DD, Mostarda C, Irigoyen MC, Morris M.Sympathetic overactivity precedes metabolic dysfunction in a fructosemodel of glucose intolerance in mice. Am J Physiol Regul IntegrComp Physiol 2012;302:R950-7.
68. Tran LT, MacLeod KK, McNeill JH. Chronic etanercept treatment preventsthe development of hypertension in fructose-fed rats. Mol CellBiochem 2009;330:219-28.
69. Kobayashi R, Nagano M, Nakamura F, Higaki J, Fujioka Y, Ikegami H,Mikami H, Kawaguchi N, Onishi S, Ogihara T. Role of angiotensin IIin high fructose induced left ventricular hypertrophy in rats. Hypertension1993;21:1051-5.
70. Baum M. Insulin stimulates volume absorption in the rabbit proximalconvoluted tubule. J Clin Invest 1987;79:1104-9.
71. Takagawa Y, Berger ME, Tuck ML, Golub MS. Impaired endothelialalpha-2 adrenergic receptor-mediated vascular relaxation in the fructose-fed rat. Hypertens Res 2002;25:197-202.
72. DeFronzo RA. Insulin resistance, hyperinsulinemia, and coronary arterydisease: a complex metabolic web. J Cardiovasc Pharmacol 1992;20:S1-16.
73. Brown IJ, Stamler J, Van Horn L, Robertson CE, Chan Q, Dyer AR,Huang CC, Rodriguez BL, Zhao L, Daviglus ML, et al.; InternationalStudy of Macro/Micronutrients and Blood Pressure Research Group-Sugar-sweetened beverage, sugar intake of individuals, and their bloodpressure: international study of macro/micronutrients and blood pressure.Hypertension 2011;57:695-701.
74. Malik AH, Akram Y, Shetty S, Malik SS, Yanchou Njike V. Impact ofsugar-sweetened beverages on blood pressure. Am J Cardiol 2014;113:1574-80.
75. Stenvinkel P, Ottosson-Seeberger A, Alvestrand A. Renal hemodynamicsand sodium handling in moderate renal insufficiency: the role ofinsulin resistance and dyslipidemia. J Am Soc Nephrol 1995;5:1751-60.
76. Hall JE, Mizelle HL, Hildebrandt DA, Brands MW. Abnormal pressurenatriuresis: a cause or a consequence of hypertension? Hypertension1990;15:547-59.
77. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulinresistance and hypertension in rats. Hypertension 1987;10:512-6.
78. Kim HY, Okubo T, Juneja LR, Yokozawa T. The protective role of amla(Emblica officinalis Gaertn.) against fructose-induced metabolic syndromein a rat model. Br J Nutr 2010;103:502-12.
79. Zhao CX, Xu X, Cui Y, Wang P, Wei X, Yang S, Edin ML, Zeldin DC,Wang DW. Increased endothelial nitric-oxide synthase expression reduceshypertension and hyperinsulinemia in fructose-treated rats. JPharmacol Exp Ther 2009;328:610-20.
80. Vasdev S, Gill V, Parai S, Longerich L, Gadag V. Dietary vitamin E andC supplementation prevents fructose induced hypertension in rats.Mol Cell Biochem 2002;241:107-14.
81. D'Angelo G, Elmarakby AA, Pollock DM, Stepp DW. Fructose feedingincreases insulin resistance but not blood pressure in Sprague-Dawleyrats. Hypertension 2005;46:806-11.
82. Brands MW, Garrity CA, Holman MG, Keen HL, Alonso-Galicia M,Hall JE. High-fructose diet does not raise 24-hour mean arterial pressurein rats. Am J Hypertens 1994;7:104-9.
83. Bezerra RM, Ueno M, Silva MS, Tavares DQ, Carvalho CR, Saad MJ,Gontijo JA. A high-fructose diet induces insulin resistance but notblood pressure changes in normotensive rats. Braz J Med Biol Res2001;34:1155-60.
84. Suzuki M, Nomura C, Odaka H, Ikeda H. Effect of an insulin sensitizer,pioglitazone, on hypertension in fructose-drinking rats. Jpn JPharmacol 1997;74:297-302.
85. Nishimoto Y, Tomida T, Matsui H, Ito T, Okumura K. Decrease in renalmedullary endothelial nitric oxide synthase of fructose-fed, saltsensitivehypertensive rats. Hypertension 2002;40:190-4.
86. Rattigan S, Clark MG, Barrett EJ. Acute vasoconstriction-induced insulinresistance in rat muscle in vivo. Diabetes 1999;48:564-9.
87. Jalal DI, Smits G, Johnson RJ, Chonchol M. Increased fructose associateswith elevated blood pressure. J Am Soc Nephrol 2010;21:1543-9.
88. Forman JP, Choi H, Curhan GC. Fructose and vitamin C intake donot influence risk for developing hypertension. J Am Soc Nephrol2009;20:863-71.
89. DiNicolantonio JJ, Lucan SC. The wrong white crystals: not salt butsugar as aetiological in hypertension and cardiometabolic disease.Open Heart 2014;1:e000167.
90. DiNicolantonio JJ, O'Keefe JH, Lucan SC. Added fructose: a principaldriver of type 2 diabetes mellitus and its consequences. Mayo ClinProc 2015;90:372-81.
91. Huang DY, Boini KM, Friedrich B, Metzger M, Just L, Oswald H,Wulff P, Kuhl D, Vallon V, Lang F. Blunted hypertensive effect of combinedfructose and high-salt diet in gene targeted mice lacking functionalserum- and glucocorticoid-inducible kinase SGK1. Am JPhysiol Regul Integr Comp Physiol 2006;290:R935-44.
92. Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I. Fructose-induced steatosis in mice:role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells. Lab Invest2011;91:885-95.
93. Jalal R, Bagheri SM, Moghimi A, Rasuli MB. Hypoglycemic effect ofaqueous shallot and garlic extracts in rats with fructose-induced insulinresistance. J Clin Biochem Nutr 2007;41:218-23.
94. Xu X, Zhao CX, Wang L, Tu L, Fang X, Zheng C, Edin ML, ZeldinDC, Wang DW. Increased CYP2J3 expression reduces insulin resistancein fructose-treated rats and db/db mice. Diabetes 2010;59:997-1005.
95. Motoyama CS, Pinto MJ, Lira FS, Ribeiro EB, do Nascimento CM,Oyama LM. Guar fiber associated with fructose reduces serum triacylglycerolbut did not improve the glucose tolerance in rats. DiabetolMetab Syndr 2010;2:1-8.
96. Faure P, Rossini E, Lafond JL, Richard MJ, Favier A, Halimi S. VitaminE improves the free radical defense system potential and insulinsensitivity of rats fed high fructose diets. J Nutr 1997;127:103-7.
97. Nandhini AT, Thirunavukkarasu V, Ravichandran MK, Anuradha CV. Effectof taurine on biomarkers of oxidative stress in tissues of fructose-fedinsulin-resistant rats. Singapore Med J 2005;46:82-7.
98. El Mesallamy HO, El-Demerdash E, Hammad LN, El Magdoub HM.Effect of taurine supplementation on hyperhomocysteinemia andmarkers of oxidative stress in high fructose diet induced insulin resistance.Diabetol Metab Syndr 2010;2:1-1146.
99. Busserolles J, Gueux E, Rock E, Demigné C, Mazur A, RayssiguierY. Oligofructose protects against the hypertriglyceridemic and prooxidativeeffects of a high fructose diet in rats. J Nutr 2003;133:1903-8.
100. Taghibiglou C, Carpentier A, Van Iderstine SC, Chen B, Rudy D, AitonA, Lewis GF, Adeli K. Mechanisms of hepatic very low density lipoproteinoverproduction in insulin resistance: evidence for enhancedlipoprotein assembly, reduced intracellular ApoB degradation, andincreased microsomal triglyceride transfer protein in a fructose-fedhamster model. J Biol Chem 2000;275:8416-25.
101. Martinez FJ, Rizza RA, Romero JC. High-fructose feeding elicits insulinresistance, hyperinsulinism, and hypertension in normal mongreldogs. Hypertension 1994;23:456-63.
102. Hallfrisch J, Ellwood KC, Michaelis OE. Effects of dietary fructose onplasma glucose and hormone responses in normal and hyperinsulinemicmen. J Nutr 1983;113:1819-26.
103. Reiser S, Powell AS, Scholfield DJ, Panda P, Ellwood KC, Canary JJ.Blood lipids, lipoproteins, apoproteins, and uric acid in men fed dietscontaining fructose or high-amylose cornstarch. Am J Clin Nutr 1989;49:832-9.